1417917-75-9

Upstream product

• 1417917-74-8 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile 
• 1417917-67-9 3-[4-(4-methoxybenzoyl)piperidin-1-yl]pyrrolidin-2-one 
• 178946-17-3 (R,S)-2,4-Dibromo-N-cyanomethyl-butyramide 
• 76362-12-4 4-(4-methoxybenzoyl)-piperidine 

Downstream Products

• 1417917-41-9 2-((3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)methyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417917-42-0 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-3H-pyrimidin-4-one 
• 1417917-43-1 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-6-methyl-3H-pyrimidin-4-one 
• 1417917-44-2 6-Ethyl-2-{3-[4-(4-methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-3H-pyrimidin-4-one 
• 1417917-46-4 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-5,6-dimethyl-3H-pyrimidin-4-one 

Relevant academic research and scientific papers

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

The present invention provides for compounds of formula (I).The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.